One cytokine sits above the rest. Dr. Hanania explains why TSLP earns the label of master regulator, and why blocking it reaches inflammation that current therapies cannot.
Geoffrey Chupp, MD, Yale School of Medicine
Advertisement
Articles by Geoffrey Chupp, MD, Yale School of Medicine
The airway epithelium is no longer understood as a passive wall. The panel traces how a barrier is now thought of as an immune organ, and what that shift means for severe asthma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD
2
Continuous Glucose Monitoring in Type 2 Diabetes, With John Anderson, MD
3
Defining On-Treatment Remission in Psoriasis and PsA
4
CHEST Guideline 2026: 13 Recommendations for Non-CF Bronchiectasis
5